Presented by
Management Forum
An Essential Overview of the Medical Device Industry Training Course
This one-day workshop aims to give all the key information necessary to understand the regulation of medical devices and diagnostics and to appreciate the key differences from pharmaceutical regulation.
★★★★★ "Both speakers were excellent and obviously knew their subject in great depth"
2 Nov 2022
- Format: Live online
- CPD: 6 hours for your records
- Certificate of completion
Course overview
The medical device and diagnostics sectors are entering a period of regulatory change with implementation of the new Medical Device Regulation (MDR) in 2020. This interactive one-day course will provide you with the key information necessary to understand the regulation of medical devices and diagnostics, and to appreciate the key differences from pharmaceutical regulation. Our expert trainers will discuss the transition and implementation of the MDR and will cover the new rules and approaches to developing combination products. The important interface with digital technology will also be explored, alongside the impact of Brexit. There will be ample opportunity for discussion throughout the day to ensure you come away with a good understanding of the medical device industry.
Who should attend?
The course has been specifically designed to meet the needs of those working in pharmaceuticals and in allied business functions who need to understand the medical device sector. It will be particularly relevant for regulatory staff and those in clinical research, medical affairs and business development.
The An Essential Overview of the Medical Device Industry course will cover:
What is a medical device and an IVD?
How is the device market developing?
An overview of the MDR and IVD Directives and the Regulations
- Challenges of MDR implementation – May 2020
- Preparation for IVDR implementation
What are the key differences in approach from pharmaceuticals?
Who are the key actors?
The role of the competent authority and authorised representative
Brexit update – impact on the medical device industry
What is a Notified Body?
How to work with a Notified Body
How are medical devices and IVDs evaluated?
What are the data requirements?
Clinical trial controls for devices
Device vigilance versus pharmacovigilance
Device/drug combination products and companion diagnostics
- The operation of Article 117 and latest guidance
Building a global approval strategy on an EU CE mark approval
The key interface with digital technology
Theresa Jeary
Theresa Jeary works for SFL as Head of Combination Products. She was previously Head of the Notified Body for Medical Devices at LRQA, where she was responsible for Devices Drug products and Class III Medical Conformity Assessment for a wide range of medical devices, including In-Vitro Fertilization Media and Solutions for Organ Preservation. Theresa has over 25 years’ experience working in both the Pharmaceutical and Medical Device industries and has worked in a variety of roles across the full development cycle from product concept and early stage development, process transfer, validation and regulatory departments, and has been a part of the team for many commercially available medicinal and medical device products.
Theresa first introduction to the Medical device Industry was as the R&D Manager for a medical device manufacturer, with responsibility for the development of several device drug combination products, with the core technology utilizing bovine collagen. Having been impressed by the innovative nature and speed of development in the Medical Device Industry, she then pursued a move to the other side of the “fence” and into the Notified Body world of Conformity Assessment. First, at BSI as a Certification Manager in the General Device group, and now with Lloyds Register Quality Assurance (LRQA).
Over the years, she has conducted many successful consultations with a large number of the European Competent Authorities as well as the European Medicines Agency (EMA) as well as reviewing the classification of borderline products. She holds a Master’s Degree in Pharmaceutical Science and is eligible to be a Pharmaceutical Qualified Person.
David Jefferys
Dr David Jefferys is Senior Vice President for Global Regulatory, Government Relations, Public Affairs and Patient Safety (EMEA, Russia and Australasia) at Eisai. After qualifying, he worked in clinical and academic medicine before spending 20 years as a senior regulator for both medicines and medical devices.
He was executive director of the UK Medicines Control Agency, CEO and Director of the MDA and joint CEO of the MHRA. He was involved in the establishment of the European Medicines Agency, is a CPMP/CHMP member and Chair of the MRFG and PER scheme. For the last ten years he has worked in industry and chairs several key committees for ABPI,EFPIA and IFPMA.
Book An Essential Overview of the Medical Device Industry Live online training
NEW higher discounts for multiple bookings - bring your colleagues to make your training budget go further:
- 30% off the 2nd delegate*
- 40% off the 3rd delegate*
- 50% off the 4th delegate*
2 Nov 2022
Live online
09:00-17:00 UK (London) (UTC+00)
10:00-18:00 Paris (UTC+01)
05:00-13:00 New York (UTC-04)
Course code 11732
- GBP 499 599
- EUR 719 859
- USD 814 970
Until 28 Sep
- 1 day live online training
- Browser-based, no download usually required
- See presenters and interact with fellow attendees
- Download documentation and certification of completion
- Fair transfer and cancellation policy
* Early booking discounts may not be combined with other discounts or offers. As such, the discounts for 2nd/3rd/4th delegates are based on the full price.
Reviews of IPI's An Essential Overview of the Medical Device Industry training course
Theresa was an excellent presenter. She presented her topic on regulatory submission and notified bodies really well. The content was clear and she had a good engagement with the delegates.
May 21 2019
Yulia Degtyareva 
Scientist, Philips
Nov 23 2017
Both speakers were excellent and obviously knew their subject in great depth
Peter Davies
Quality Engineer, Bespak Europe Ltd
Nov 23 2017
Enjoyed the course, felt the topics were covered in enough detail given the subject matter. Informal atmosphere with a small number of delegates meant opportunity for questions which were welcomed. Both speakers were clearly passionate about their subject and this was evident during their presentations.
Gillian Hakewill
Regulatory Affairs Officer, SPD Development Company Limited
Nov 23 2017
The course was delivered by highly educated industry experts who shared their extensive knowledge in a clear and entertaining manner. The delegate numbers were small which allowed for a very personal service. I will be recommending Management Forum courses to my colleagues.
Stephanie Kirby
Senior Regulatory Affairs Officer, Bells Healthcare
May 19 2017
Just brilliant – speakers were so very knowledgeable
Valentina Curran
Senior Medical Affairs Executive, Norgine Ltd.
May 19 2017
The course material is very good. The speakers were excellent and the manner in which they presented.
Jovana Jevtic
Bard Pharmaceuticals Ltd
May 19 2017
The course is great for people having no idea about the medical device industry. Makes you understand the key differences between pharmaceuticals and medical devices in terms of regulations and vigilance.
Francois Rugiero
Convergence Pharmaceuticals
Nov 23 2017
Very nice overview
Camiel Kulker 
Senior Regulatory Affairs Manager , Astellas Pharma Europe B.V.
May 19 2017
Well presented - clear and concise.
Paul Glennie
Project Manager, Napp Pharmaceuticals Ltd
Nov 11 2016
Good content
Anna Somuyiwa
Regulatory Affairs Consultant , Segulah Consulting Limited
Nov 11 2016
Did what it said on the tin - personally would like to see more of a marketing focus than regulatory but the day delivered what it promised.
Richard Addy
Senior Director, Customer Success, Veeva
Nov 11 2016
Excellent course, pitched at the right level for people new to this area of work.
Dolores Cassidy 
Patent Examiner, Irish Patents Office
Nov 11 2016
Excellent course, pitched at the right level for people new to this area of work
Dolores Cassidy
Patent Examiner, Irish Patents Office
United Kingdom
- A.A. Thornton & Co
- Bard Pharmaceuticals
- Bard Pharmaceuticals Ltd
- Bayer plc
- Bayer Public Limited Company
- Bells Healthcare
- Bespak Europe Ltd
- Convergence Pharmaceuticals
- Drug Safety Solutions Ltd
- Healthcare at Home Ltd
- ISIS Pharma Consulting Ltd
- McKesson
- Meda Pharmaceuticals Limited
- Medicines & Healthcare Regulatory Agency
- Medicines and Healthcare Products Regulatory Agency (MHRA)
- MHRA/NIBSC
- Mylan
- Napp Pharmaceuticals Ltd
- National Biofilms Innovation Centre
- Newcastle University
- Norgine Ltd
- Norgine Ltd.
- Pharmacovigilance Matters Limited
- Philips
- Proprietary Association Of Great Britain
- Quanticate
- Red Line Pharmacovigilance Ltd
- RWS Translations Ltd
- Segulah Consulting Limited
- Smith & Nephew Healthcare
- Smith & Nephew plc
- SPD Development Company Limited
- Teva Pharmaceuticals Ltd
- TEVA UK
- Veeva
Ireland
- Abbott Diagnostics Division
- ICON plc
- Irish Patents Office
- Novartis Ireland Ltd
France
- IPSEN Pharma
- Ipsen Pharma SAS
- Université Paris Sud
Belgium
- Toxikon Europe NV
- UCB S.A.
Switzerland
- F. Hoffmann-La Roche Ltd
- TRB Chemedica International SA
Denmark
- Ferring Pharmaceutical A/S
Germany
- Boehringer Ingelheim Vetmedica GmbH
Isle of Man
- Panacea Pharma Projects
Netherlands
- Astellas Pharma Europe B.V.
Run An Essential Overview of the Medical Device Industry Live online for your team
1 day
Typical duration
Pricing from:
- GBP 450
- Per attendee
- Course tailored to your requirements
- At your choice of location, or online
We can customise this course to your requirements and deliver it on an in-house basis for any number of your staff or colleagues.
Contact our in-house training expert Aleksandra Beer to discuss your requirements:
